Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Kraken Zone Discovery Unlocks Significant Value (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Breaking & Recent News Senseonics Holdings Inc SENS

Healthcare Medical Devices
Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365, which are implantable CGM systems to measure glucose levels in people with... see more

Recent & Breaking News (NDAQ:SENS)

Senseonics Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results

GlobeNewswire 2 days ago

Sequel Med Tech and Senseonics Launch Transformative Combination of twiist(TM) and Eversense® 365

GlobeNewswire 13 days ago

Senseonics Receives European Approval for Eversense 365, World's Longest-lasting Continuous Glucose Monitor

GlobeNewswire January 29, 2026

Senseonics Holdings, Inc. to Participate at the BTIG 13th Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference

GlobeNewswire January 28, 2026

Senseonics Announces Preliminary Unaudited Revenue for Fourth Quarter 2025 and Provides Business Update

GlobeNewswire January 12, 2026

Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist(TM) Automated Insulin Delivery (AID) System

GlobeNewswire January 8, 2026

Senseonics Holdings, Inc. to Participate in the Stifel 2025 Healthcare Conference

GlobeNewswire November 10, 2025

Senseonics Announces Transfer to Nasdaq Stock Exchange

GlobeNewswire November 10, 2025

Senseonics Holdings, Inc. Reports Third Quarter Financial Results

GlobeNewswire November 5, 2025

Senseonics Holdings, Inc. Schedules Third Quarter 2025 Earnings Release and Conference Call for November 5, 2025 at 4:30 P.M. Eastern Time

GlobeNewswire October 22, 2025

Senseonics Announces Preliminary Unaudited Revenue for Third Quarter 2025 and Provides Business Update

GlobeNewswire October 6, 2025

Senseonics Signs Memorandum of Understanding with Ascensia Diabetes Care to Take Over Commercialization and Distribution of Eversense 365

GlobeNewswire September 3, 2025

Senseonics Holdings, Inc. Reports Second Quarter Financial Results

GlobeNewswire August 6, 2025

Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time

GlobeNewswire July 16, 2025

Senseonics Holdings, Inc. to Host In-Person and Virtual Analyst Event at ADA 2025: Eversense® 365 Continuous Glucose Monitoring System for People with Diabetes

GlobeNewswire June 4, 2025

Senseonics Holdings, Inc. Announces Closing of Public Offering, Including Exercise in Full of the Underwriters' Option to Purchase Additional Shares, and Closing of Private Placement

GlobeNewswire May 21, 2025

Senseonics Announces Pricing of $50 Million Public Offering of Common Stock and Concurrent Private Placement

GlobeNewswire May 15, 2025

Senseonics Announces Commencement of $50 Million Public Offering of Common Stock and Concurrent Private Placement

GlobeNewswire May 15, 2025

Senseonics Holdings, Inc. Reports First Quarter Financial Results

GlobeNewswire May 8, 2025

Senseonics Holdings, Inc. Schedules First Quarter 2025 Earnings Release and Conference Call for May 8, 2025 at 4:30 P.M. Eastern Time

GlobeNewswire April 29, 2025

Podcasts